ClinicalTrials.Veeva

Menu

Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube in Modified Radical Mastectomy on Breast Cancer (LMATBBC)

N

Nanjing Medical University

Status and phase

Completed
Phase 4

Conditions

Breast Cancer

Treatments

Device: Endotracheal tube
Device: LMA®

Study type

Interventional

Funder types

Other

Identifiers

NCT00638599
NMU075451
NMU-2579-7FW

Details and patient eligibility

About

Airway management in anesthesia is critical to guarantee appropriate treatment of possible respiratory complications and successful operative practice. LMA® is an alternative to tracheal tube in some surgeries like as mastectomy on breast cancer. Given no need using muscular relaxants in mastectomy, the investigators hypothesized that LMA® would be a superior manner in airway management in radical modified mastectomy on breast cancer than the tracheal tube, and the LMA® might produce less influence on patients' circulatory homeostasis, and easier to be placed before operation.

Enrollment

200 patients

Sex

Female

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chinese
  • Diagnosed breast cancer
  • Undergoing modified radical mastectomy
  • Agreed to participate the study with informed contract.

Exclusion criteria

  • Organic dysfunction
  • Long-lasting post-anesthetic care unit(PACU) staying.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

1
Experimental group
Description:
LMA® is placed after anesthesia induction till the end of operation
Treatment:
Device: LMA®
2
Active Comparator group
Description:
Standard tracheal tube is inserted after anesthesia induction till the end of operation
Treatment:
Device: Endotracheal tube

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems